Catalyst Biosciences, Inc. Ownership
$6.10
11.31%
Nasdaq, Fri, Sep 25 2026.
Catalyst Biosciences, Inc. Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Goodwood Inc.
|
257.257k | 24.27% | — | Jun 03 2025 |
| 2 |
Puccetti (Peter H)
|
15.687k | 1.48% | +15.687k | Mar 24 2026 |
| 3 |
Kosciessa (Ulrich)
|
1.848k | 0.17% | — | Mar 24 2026 |
| 4 |
Planning Capital Management Corp
|
2.000 | 0.00% | — | Sep 30 2024 |
| 5 |
National Bank of Canada
|
0.000 | 0.00% | -1.149k | Sep 30 2025 |
|
1
Goodwood Inc.
|
24.27%
257.257k
|
|
2
Puccetti (Peter H)
|
1.48%
15.687k
|
|
3
Kosciessa (Ulrich)
|
0.17%
1.848k
|
|
4
Planning Capital Management Corp
|
0.00%
2.000
|
|
5
National Bank of Canada
|
0.00%
0.000
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 25.92% of Catalyst Biosciences, Inc., with Goodwood Inc. the biggest at 24.27%, followed by Puccetti (Peter H) (1.48%) and Kosciessa (Ulrich) (0.17%). |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
